Papamatheakis Demosthenes G, Kim Nick H
Division of Pulmonary and Critical Care Medicine, University of California San Diego, 9300 Campus Point Dr. MC 7381, La Jolla, CA, 92037, USA.
Curr Hypertens Rep. 2015 Sep;17(9):582. doi: 10.1007/s11906-015-0582-9.
Chronic thromboembolic pulmonary hypertension (CTEPH), a potentially curable form of pulmonary hypertension with pulmonary thromboendarterectomy surgery, has been the focus of significant medical advances. In addition to new imaging modalities that are now used to help recognize and diagnose CTEPH, additional treatment options have emerged for inoperable cases. These include a newly approved medical therapy for inoperable disease or persistent/recurrent CTEPH as well as percutaneous balloon angioplasty of the pulmonary arteries. In this article, we summarize these recent advances in the field and review the related literature.
慢性血栓栓塞性肺动脉高压（CTEPH）是一种可通过肺动脉血栓内膜剥脱术治愈的肺动脉高压，一直是重大医学进展的焦点。除了现在用于帮助识别和诊断CTEPH的新成像方式外，对于无法手术的病例也出现了更多的治疗选择。这些包括一种新批准的用于无法手术的疾病或持续性/复发性CTEPH的药物治疗以及肺动脉经皮球囊血管成形术。在本文中，我们总结了该领域的这些最新进展并回顾了相关文献。
